Skip to main content
. 2023 Jul 13;16:1215637. doi: 10.3389/fnmol.2023.1215637

Table 4.

Brain urea fold-change comparisons between VaD and other age-related dementias.

Brain region Fold-change in VaD (this study) Fold-change in AD (Xu et al., 2016) Fold-change in HD (Patassini et al., 2015) Fold-change in PDD (Scholefield et al., 2021)
Hippocampus 2.4 6.5 3.6 4.2
Cingulate gyrus 2.3 5.3 3.5 5.5
Middle temporal gyrus 2.2 4.7 3.4 4.3
Occipital cortex 2.3 4.3
Frontal gyrus 2.0 3.0
Basal ganglia 2.4
Thalamus 2.3
Sensory cortex 4.9 3.4
Cerebellum 4.9 3.6 3.7
Motor cortex 5.0 3.4 4.1
Substantia nigra 3.9
Medulla 4.6
Pons 3.9
Putamen 3.7
Globus pallidus 3.6
Entorhinal cortex 5.6 2.8
Overall 2.2 (2.1–2.4) 5.3 (4.8–5.8) 3.4 (3.2–3.6) 4.3 (3.9–4.6)
Overall disease comparison 2.3 (2.1–2.5) 5.5 (3.2–7.8) 3.5 (3.3–3.8) 4.6 (2.9–6.5)

Brain urea case-control fold-change comparisons between VaD (n = 10), AD (n = 9), HD (n = 9), and PDD (n = 9). Fold-change represents cases divided by the controls. Overall signifies the mean overall fold-change (±95% CI) for each investigation. Overall disease comparison signifies the mean overall fold-change (±95% CI) for all regions that were used for the multi-disease comparisons (highlighted in gray). Number of controls used in each cohort are as follows: VaD (n = 8/9), AD (n = 9), HD (n = 9), and PDD (n = 9). The order or urea fold-change across these dementias from highest to lowest is AD, PDD, HD, and lastly VaD.

Only VaD urea levels in the FG were non-significant. All other values had value of ps < 0.05.